Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myeloma
Sophia Ascione,
Stéphanie Harel,
Florent L. Besson,
Rakiba Belkhir,
Julien Henry,
Bruno Royer,
Bertrand Arnulf,
Xavier Mariette,
Raphaèle Seror
Affiliations
Sophia Ascione
Department of Rheumatology, AP-HP, Hôpital Bicêtre, Le Kremlin Bicêtre
Stéphanie Harel
Department of Immunohematology, AP-HP, Hôpital Saint-Louis, Paris
Florent L. Besson
Department of Biophysics and Nuclear Medicine-Molecular Imaging, AP-HP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; Université Paris-Saclay, CEA, CNRS, Inserm, BioMaps, Orsay, 91401
Rakiba Belkhir
Department of Rheumatology, AP-HP, Hôpital Bicêtre, Le Kremlin Bicêtre
Julien Henry
Department of Rheumatology, AP-HP, Hôpital Bicêtre, Le Kremlin Bicêtre
Bruno Royer
Department of Immunohematology, AP-HP, Hôpital Saint-Louis, Paris
Bertrand Arnulf
Department of Immunohematology, AP-HP, Hôpital Saint-Louis, Paris
Xavier Mariette
Department of Rheumatology, AP-HP, Hôpital Bicêtre, Le Kremlin Bicêtre, France; Center of Immunology of Viral Infections and Auto-immune Diseases (IMVA), INSERM UMR1184, Université Paris-Saclay, Le Kremlin Bicêtre
Raphaèle Seror
Department of Rheumatology, AP-HP, Hôpital Bicêtre, Le Kremlin Bicêtre, France; Center of Immunology of Viral Infections and Auto-immune Diseases (IMVA), INSERM UMR1184, Université Paris-Saclay, Le Kremlin Bicêtre